/
|
66
|
98
|
184
|
|
MAX
|
/
|
5
|
5
|
|
TMEM127
|
/
|
2
|
6
|
|
EPAS1
|
/
|
2
|
0
|
|
Familial pituitary adenomas
|
AIP
|
/
|
10
|
4
|
14
|
|
Ataxia–telangiectasia
|
ATM
|
BI
|
23
|
5
|
59
|
|
MONO
|
2
|
27
|
|
MRE11A
|
BI
|
0
|
0
|
|
MONO
|
0
|
2
|
|
Hereditary papillary renal carcinoma
|
FH
|
/
|
20
|
12
|
37
|
|
MET
|
/
|
3
|
2
|
|
Hematologic malignancies
|
**
|
/
|
14
|
1
|
15
|
|
Hyperparathyroidism
|
CDC73
|
/
|
19
|
16
|
51
|
|
CASR
|
/
|
16
|
0
|
|
Cowden syndrome
|
PTEN
|
/
|
24
|
21
|
51
|
|
PIK3CA
|
/
|
6
|
0
|
|
Fanconi syndrome
|
FANC
|
BI
|
17
|
10
|
50
|
|
MONO
|
5
|
17
|
|
RAD51
|
BI
|
0
|
0
|
|
MONO
|
0
|
1
|
|
Familial malignant melanoma
|
CDKN2A
|
/
|
28
|
26
|
120
|
|
BAP1
|
/
|
31
|
11
|
|
MITF
|
/
|
20
|
0
|
|
POT1
|
/
|
3
|
0
|
|
CDK4
|
/
|
1
|
0
|
|
Neurofibromatosis
|
NF1
|
/
|
430
|
137
|
682
|
|
NF2
|
/
|
36
|
3
|
|
LZTR1
|
/
|
30
|
3
|
|
SMARCB1
|
/
|
10
|
3
|
|
SPRED1
|
/
|
18
|
8
|
|
SMARCE1
|
/
|
4
|
0
|
|
RASopathies and Noonan syndrome
|
***
|
/
|
159
|
NR
|
159
|
|
Retinoblastoma
|
RB1
|
/
|
29
|
6
|
35
|
|
Birt–Hogg–Dubé syndrome
|
FLCN
|
/
|
112
|
55
|
167
|
|
Bloom syndrome
|
BLM
|
BI
|
0
|
2
|
5
|
|
MONO
|
0
|
3
|
|
Carney complex
|
ARMC5
|
/
|
10
|
5
|
